What Exactly Is Patient Safety?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Global Patient Safety Action Plan 2021–2030 Towards Eliminating Avoidable Harm in Health Care
GLOBAL PATIENT SAFETY ACTION PLAN 2021–2030 Towards Eliminating Avoidable Harm in Health Care Second Draft November 2020 Table of Contents Overview of the Global Patient Safety Action Plan 2021–2030 ................................................................................................................v Abbreviations ............................................................................................................................................................................................................vii 1. Introduction .........................................................................................................................................................................................................1 Background .................................................................................................................................................................................................1 The emergence of patient safety thinking .....................................................................................................................2 The global burden of unsafe care ......................................................................................................................................2 The evolution of the global patient safety movement ..............................................................................................3 COVID–19: A broader concept of avoidable harm ......................................................................................................6 -
A Health Equity Lens on Patient Safety and Quality
UCSF Center for Vulnerable UCSF School UCSF Department Populations at Zuckerberg of Medicine of Epidemiology San Francisco General and Biostatistics Hospital A Health Equity Lens on Patient Safety and Quality Kirsten Bibbins-Domingo, PhD, MD, MAS Lee Goldman, MD Endowed Chair in Medicine Professor of Epidemiology and Biostatistics and Medicine Vice Dean for Population Health and Health Equity 10/26/2018 Braveman P, Arkin E, Orleans T, Proctor D, and Plough A. What Is Health Equity? And What Difference Does a Definition Make? Princeton, NJ: Robert Wood Johnson Foundation, 2017. Partnering for Health Equity . The fierce urgency of now Can we advance patient safety AND equity at the same time? 4 YES! Deliberate action, Informed choices, Creating a culture of quality and safety for all 5 The inequality paradox 6 Frohlich and Potvin, AJPH 2008 Number and percentage of quality measures for which income groups experienced better, same, or worse quality of care compared with reference group (high income), 2014-2015 7 AHRQ 2016 National Healthcare Quality and Disparities Report Number and percentage of quality measures with disparity at baseline for which disparities related to income were improving, not changing, or worsening (2000 through 2014-2015) 8 AHRQ 2016 National Healthcare Quality and Disparities Report Number and percentage of quality measures for which members of selected groups experienced better, same, or worse quality of care compared with reference group (White) in 2014-2015 9 AHRQ 2016 National Healthcare Quality and Disparities Report Number and percentage of quality measures with disparity at baseline for which disparities related to race and ethnicity were improving, not changing, or worsening (2000 through 2014-2015) 10 AHRQ 2016 National Healthcare Quality and Disparities Report Number and percentage of quality and access measures for which members of selected groups experienced better, same, or worse quality of care compared with reference group in 2014-2015, by geographic location 11 AHRQ 2016 National Healthcare Quality and Disparities Report 1. -
TIN CAS Number
Common Name: TIN CAS Number: 7440-31-5 RTK Substance number: 1858 DOT Number: None Date: January 1986 Revision: April 2001 ------------------------------------------------------------------------- ------------------------------------------------------------------------- HAZARD SUMMARY WORKPLACE EXPOSURE LIMITS * Tin can affect you when breathed in. OSHA: The legal airborne permissible exposure limit * Contact can irritate the skin and eyes. (PEL) is 2 mg/m3 averaged over an 8-hour * Breathing Tin can irritate the nose, throat and lungs workshift. causing coughing, wheezing and/or shortness of breath. * Tin can cause nausea, vomiting, diarrhea and abdominal NIOSH: The recommended airborne exposure limit is pain, headache, fatigue and tremors. 2 mg/m3 averaged over a 10-hour workshift. * Tin can cause "spots" to appear on chest x-ray with normal lung function (stannosis). ACGIH: The recommended airborne exposure limit is 3 * Tin may damage the liver and kidneys. 2 mg/m averaged over an 8-hour workshift. * High exposure can affect the nervous system. WAYS OF REDUCING EXPOSURE IDENTIFICATION * Where possible, enclose operations and use local exhaust Tin is a soft, white, silvery metal or a grey-green powder. It ventilation at the site of chemical release. If local exhaust is found in alloys, Babbitt and similar metal types, and is used ventilation or enclosure is not used, respirators should be as a protective coating and in glass bottle and can worn. manufacturing. * Wear protective work clothing. * Wash thoroughly immediately after exposure to Tin. REASON FOR CITATION * Post hazard and warning information in the work area. In * Tin is on the Hazardous Substance List because it is addition, as part of an ongoing education and training regulated by OSHA and cited by ACGIH and NIOSH. -
Improving Quality and Achieving Equity: a Guide for Hospital Leaders
Institute for Health Policy Improving Quality and Achieving Equity: A Guide for Hospital Leaders 1 2 Improving Quality and Achieving Equity: A Guide for Hospital Leaders Acknowledgements The Disparities Solutions Center would like to extend our sincerest gratitude to The Robert Wood Johnson Foundation for their generous support for the development and design of Improving Quality and Achieving Equity: A Guide for Hospital Leaders, and in particular Pamela Dickson, MBA, formerly our Project Officer, now Deputy Director of the Health Care Group, for her guidance and advice. We would like to extend our special thanks to all of the hospital leaders who agreed to be interviewed for this project, as well as the hospitals who allowed us to conduct a more extended site visit to develop the case studies presented here. We would also like to thank our Sounding Board for this project, which provided input and feedback from conception to design, as well as the reviewers who graciously agreed to share their perspectives and expertise to make this a practical, effective tool for real-world hospital leaders. We are deeply appreciative of Ann McAlearney, ScD, MS, Assistant Professor, Division of Health Services Management and Policy, Ohio State University School of Public Health, and Sunita Mutha, MD, FACP, Associate Professor of Clinical Medicine, Center for the Health Professions, Division of General Internal Medicine, University of California, San Francisco, who shared key resources and perspectives. Special thanks go to the leadership and administration of the Institute for Health Policy, and in particular the Institute’s Director, Dr. David Blumenthal, Associate Director, Dr. -
Healthcare Reform in Russia: Problems and William Tompson Prospects
OECD Economics Department Working Papers No. 538 Healthcare Reform in Russia: Problems and William Tompson Prospects https://dx.doi.org/10.1787/327014317703 Unclassified ECO/WKP(2006)66 Organisation de Coopération et de Développement Economiques Organisation for Economic Co-operation and Development 15-Jan-2007 ___________________________________________________________________________________________ _____________ English text only ECONOMICS DEPARTMENT Unclassified ECO/WKP(2006)66 HEALTHCARE REFORM IN RUSSIA: PROBLEMS AND PROSPECTS ECONOMICS DEPARTMENT WORKING PAPERS No. 538 By William Tompson All Economics Department Working Papers are available through OECD's website at www.oecd.org/eco/working_papers text only English JT03220416 Document complet disponible sur OLIS dans son format d'origine Complete document available on OLIS in its original format ECO/WKP(2006)66 ABSTRACT/RÉSUMÉ Healthcare Reform in Russia: Problems and Prospects This paper examines the prospects for reform of Russia’s healthcare system. It begins by exploring a number of fundamental imbalances that characterise the current half-reformed system of healthcare provision before going on to assess the government’s plans for going ahead with healthcare reform over the medium term. The challenges it faces include strengthening primary care provision and reducing the current over-reliance on tertiary care; restructuring the incentives facing healthcare providers; and completing the reform of the system of mandatory medical insurance. This paper relates to the OECD Economic Survey of the Russian Federation 2006 (www.oecd.org/eco/surveys/russia). JEL classification: I11, I12, I18 Keywords: Russia; healthcare; health insurance; competition; primary care; hospitalisation; pharmaceuticals; single payer; ***************** La reforme du système de santé en Russie: problèmes et perspectives La présente étude analyse les perspectives de réforme du système de santé en Russie. -
Five Keys to Safer Food Manual
FIVE KEYS TO SAFER FOOD MANUAL DEPARTMENT OF FOOD SAFETY, ZOONOSES AND FOODBORNE DISEASES FIVE KEYS TO SAFER FOOD MANUAL DEPARTMENT OF FOOD SAFETY, ZOONOSES AND FOODBORNE DISEASES INTRODUCTION Food safety is a significant public health issue nsafe food has been a human health problem since history was first recorded, and many food safety Uproblems encountered today are not new. Although governments all over the world are doing their best to improve the safety of the food supply, the occurrence of foodborne disease remains a significant health issue in both developed and developing countries. It has been estimated that each year 1.8 million people die as a result of diarrhoeal diseases and most of these cases can be attributed to contaminated food or water. Proper food preparation can prevent most foodborne diseases. More than 200 known diseases are transmitted through food.1 The World Health Organization (WHO) has long been aware of the need to educate food handlers about their responsibilities for food safety. In the early 1990s, WHO developed the Ten Golden Rules for Safe Food Preparation, which were widely translated and reproduced. However, it became obvious that something simpler and more generally applicable was needed. After nearly a year of consultation with food safety expertsandriskcommunicators, WHOintroducedtheFive KeystoSaferFoodposterin2001.TheFive Keys toSaferFoodposterincorporatesallthemessagesoftheTen Golden Rules for Safe Food Preparation under simpler headings that are more easily remembered and also provides more details on the reasoning behind the suggested measures. The Five Keys to Safer Food Poster The core messages of the Five Keys to Safer Food are: (1) keep clean; (2) separate raw and cooked; (3) cook thoroughly; (4) keep food at safe temperatures; and (5) use safe water and raw materials. -
Hand Hygiene: Clean Hands for Healthcare Personnel
Core Concepts for Hand Hygiene: Clean Hands for Healthcare Personnel 1 Presenter Russ Olmsted, MPH, CIC Director, Infection Prevention & Control Trinity Health, Livonia, MI Contributions by Heather M. Gilmartin, NP, PhD, CIC Denver VA Medical Center University of Colorado Laraine Washer, MD University of Michigan Health System 2 Learning Objectives • Outline the importance of effective hand hygiene for protection of healthcare personnel and patients • Describe proper hand hygiene techniques, including when various techniques should be used 3 Why is Hand Hygiene Important? • The microbes that cause healthcare-associated infections (HAIs) can be transmitted on the hands of healthcare personnel • Hand hygiene is one of the MOST important ways to prevent the spread of infection 1 out of every 25 patients has • Too often healthcare personnel do a healthcare-associated not clean their hands infection – In fact, missed opportunities for hand hygiene can be as high as 50% (Chassin MR, Jt Comm J Qual Patient Saf, 2015; Yanke E, Am J Infect Control, 2015; Magill SS, N Engl J Med, 2014) 4 Environmental Surfaces Can Look Clean but… • Bacteria can survive for days on patient care equipment and other surfaces like bed rails, IV pumps, etc. • It is important to use hand hygiene after touching these surfaces and at exit, even if you only touched environmental surfaces Boyce JM, Am J Infect Control, 2002; WHO Guidelines on Hand Hygiene in Health Care, WHO, 2009 5 Hands Make Multidrug-Resistant Organisms (MDROs) and Other Microbes Mobile (Image from CDC, Vital Signs: MMWR, 2016) 6 When Should You Clean Your Hands? 1. Before touching a patient 2. -
Guide to Developing the Safety Risk Management Component of a Public Transportation Agency Safety Plan
Guide to Developing the Safety Risk Management Component of a Public Transportation Agency Safety Plan Overview The Public Transportation Agency Safety Plan (PTASP) regulation (49 C.F.R. Part 673) requires certain operators of public transportation systems that are recipients or subrecipients of FTA grant funds to develop Agency Safety Plans (ASP) including the processes and procedures necessary for implementing Safety Management Systems (SMS). Safety Risk Management (SRM) is one of the four SMS components. Each eligible transit operator must have an approved ASP meeting the regulation requirements by July 20, 2020. Safety Risk Management The SRM process requires understanding the differences between hazards, events, and potential consequences. SRM is an essential process within a transit The Sample SRM Definitions Checklist can support agencies agency’s SMS for identifying hazards and analyzing, as- with understanding and distinguishing between these sessing, and mitigating safety risk. Key terms, as de- terms when considering safety concerns and to help ad- fined in Part 673, include: dress Part 673 requirements while developing the SRM • Event–any accident, incident, or occurrence. section of their ASP. • Hazard–any real or potential condition that can cause injury, illness, or death; damage to or loss of the facilities, equipment, rolling stock, or infra- structure of a public transportation system; or damage to the environment. • Risk–composite of predicted severity and likeli- hood of the potential effect of a hazard. • Risk Mitigation–method(s) to eliminate or re- duce the effects of hazards. Sample SRM Definitions Checklist The following is not defined in Part 673. However, transit Part 673 requires transit agencies to develop and imple- agencies may choose to derive a definition from other text ment an SRM process for all elements of its public provided in Part 673, such as: transportation system. -
Top 10 Patient Safety Concerns for Healthcare Organizations 2018
Executive Brief Top 10 Patient Safety Concerns for Healthcare Organizations 2018 years WANT MORE? This executive brief summarizes ECRI Institute’s Top 10 list of patient safety concerns for 2018. Healthcare Risk Control (HRC) and ECRI Institute PSO members can access the full report, which discusses each topic in more detail, by logging in at https://www.ecri.org. Additionally, page 14 of this brief lists ECRI Institute resources that provide more in-depth guidance for each topic. Top 10 Patient Safety Concerns for Healthcare Organizations 2018 Healthcare is striving to become an industry ECRI Institute’s Top 10 Patient Safety Concerns for 2018 of high-reliability organizations, and part 1 Diagnostic errors of being a high-reliability industry means 2 Opioid safety across the continuum of care staying vigilant and identifying problems proactively. This annual Top 10 list helps 3 Internal care coordination organizations identify looming patient safety 4 Workarounds challenges and offers suggestions and Incorporating health IT into patient safety programs resources for addressing them. 5 Management of behavioral health needs in 6 acute care settings Why We Create This List 7 All-hazards emergency preparedness ECRI Institute creates this annual list of 8 Device cleaning, disinfection, and sterilization Top 10 patient safety concerns to support 9 Patient engagement and health literacy healthcare organizations in their efforts to proactively identify and respond to threats 10 Leadership engagement in patient safety MS130 to patient safety. This report offers perspectives from some of our many experts, as well as links to further guidance on addressing these issues. MARCH 2018 Adapted from: Top 10 Patient Safety Concerns for Healthcare Organizations 2018. -
Safety and Health Injury Prevention Sheets (SHIPS)
Occupational Safety and Health Administration S AFETY and H EALTH I NJURY P REVENTION S HEETS Working with the Shipyard Industry Occupational Safety and Health Shipbuilding,Ship Repair Administration and Ship Breaking Introduction : Working with the ShipyardShipyard IndustrIndustryy Shipyards operating in the United States often do not have the benefit of full-time, on-board safety and health specialists. Although help is available from workers’ compensation loss control consultants, or state consultation services, their consultants are not always familiar with the unique aspects and hazards of shipyard operations. To meet this need and help prevent injuries, the shipyard community and OSHA have jointly developed Safety and Health Injury Prevention Sheets (SHIPS). Representatives of large and small shipyards around the country assisted OSHA in identifying the most frequent hazards and injuries in shipbuilding and ship repair work. Designed for both employers and workers, SHIPS presents information on hazard awareness and controls in a user-friendly format. Pictures from actual shipyards depict hazards and recommended solutions. The time-tested solutions presented are those the shipyard community has found to be most effective in reducing or eliminating shipyard injuries. The goal of SHIPS is to reduce or eliminate unsafe work practices by increasing employer and worker awareness of safety and health hazards. The first SHIPS presented is Hot Work-Welding, Cutting and Brazing. Some of the material may need to be adapted to different size shipyards and different local conditions. We hope that you will find the information helpful in setting up a plan to make your shipyard a safer and more healthful place to work. -
Leadership Guide to Patient Safety
Innovation Series 2006 Leadership Guide to Patient Safety 12 We have developed IHI’s Innovation Series white papers to further our mission of improving the quality and value of health care. The ideas and findings in these white papers represent innovative work by organizations affiliated with IHI. Our white papers are designed to share with readers the problems IHI is working to address; the ideas, changes, and methods we are developing and testing to help organizations make breakthrough improvements; and early results where they exist. Copyright © 2006 Institute for Healthcare Improvement All rights reserved. Individuals may photocopy all or parts of white papers for educational, not-for- profit uses. These papers may not be reproduced for commercial, for-profit use in any form, by any means (electronic, mechanical, xerographic, or other) or held in any information storage or retrieval system without the written permission of the Institute for Healthcare Improvement. How to cite this paper: Botwinick L, Bisognano M, Haraden C. Leadership Guide to Patient Safety. IHI Innovation Series white paper. Cambridge, Massachusetts: Institute for Healthcare Improvement; 2006. (Available on www.IHI.org) Acknowledgements: The Institute for Healthcare Improvement (IHI) would like to thank the following individuals for their contributions to the work: Donald M. Berwick, MD, MPP, FRCP, President and CEO, IHI Donald Goldmann, MD, Senior Vice President, IHI Frances A. Griffin, RRT, MPA, Director, IHI Julianne Morath, RN, MS, Chief Operating, Children’s Hospitals and Clinics of Minnesota Gail A. Nielsen, BSHCA, Clinical Performance Improvement Education Administrator, Iowa Health System, and IHI George W. Merck Fellow 2004–2005 Thomas Nolan, PhD, Statistician, Associates in Process Improvement, and IHI Senior Fellow James L. -
Pharmacovigilance Monitoring Product Safety to Protect Patients
ETHICS AND TRANSPARENCY PHARMACOVIGILANCE MONITORING PRODUCT SAFETY TO PROTECT PATIENTS GRI Standards : 103: Management approach 417: Marketing and Labeling EXECUTIVE SUMMARY Monitoring the quality, efficacy and safety of our products throughout their life cycle, from clinical development to prescription and consumption, is a priority to protect patient safety. Some rare or late onset adverse events are often only detected at this time. In order to maximize our knowledge on the use of our portfolio in real-world conditions, Sanofi's Global Pharmacovigilance Department (GPV) has established an effective global organization to passively and actively collect pharmacovigilance data from all sources of information around the world. Thanks to this data collection, the teams monitor safety and are able to adjust the benefit-risk profile of our products: prescription medicines, vaccines, consumer health products, generics, and medical devices. Pharmacovigilance helps determine the best conditions of use for treatments, and provides physicians, healthcare professionals and patients with comprehensive, up-to-date safety information, including potential risks associated with a product. Pharmacovigilance Factsheet 1 Published April 2020 TABLE OF CONTENTS 1. DEFINITION .................................................................................................................. 3 2. THE PURPOSE OF PHARMACOVIGILANCE ............................................................. 3 3. A BEST-IN-CLASS PHARMACOVIGILANCE ORGANIZATION ................................. 3 Pharmacovigilance Factsheet 2 Published April 2020 1. DEFINITION Pharmacovigilance is the process of monitoring the safety and contributing to the continuous assessment of the benefit-risk profile of our products at every stage of their life cycle. 2. THE PURPOSE OF PHARMACOVIGILANCE The diagram below summarizes the purpose of pharmacovigilance in an international pharmaceutical company in line with regulatory requirements : Figure 1 : The purpose of product safety monitoring is threefold 3.